The national Medilink UK Healthcare Business Awards 2021 shortlist has been revealed, with some of the most innovative life sciences organisations in UK making the final list. The awards look back over the last 12 months and provide a platform for life science organisations to...
Glasgow, UK, 21 September 2021 – Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced the appointment of Joshua T. Brumm as its new Independent Chairman, succeeding Satish Jindal. Amphista’s CEO Dr Nicola Thompson said, “On behalf of the Amphista team I...
DevelRx, a company based in BioCity Nottingham, is delighted to announce a new partnership with Scitegrity (Discovery Park, Kent). DevelRx is an internationally recognised consultancy business founded in 2020 that provides expert support on CNS (central nervous system) drug discovery and development to all sectors of the...
Cambridge, UK – 14 September 2021 – Cresset Discovery Services, provider of contract research services for early phase of drug discovery, has announced it will collaborate with the University of Newcastle, Australia, to focus on drug reprofiling against oncology targets. The work will build on...
Nottingham based contract research organisation (CRO) Cellomatics Biosciences has reported year-on-year organic revenue growth of 30 percent since its inception in 2015, as demand for its bespoke preclinical and early discovery phase laboratory services and expertise continues to soar. Based at BioCity Nottingham, Cellomatics is a...
Lanarkshire-based biotechnology company ILC Therapeutics has completed a £3.5m pre-IPO funding round. Investors include Los Angeles-based lawyer and investor Robert Kopple; St Andrews-based Eos Angel Investment Syndicate; Scottish Enterprise; and members of ILCT's management. Kopple, along with St Andrews University Professor David Harrison and Association of the...
Investors include Mercia Asset Management and BGF Funding to further advance Locate Bio’s regenerative medicine pipeline of orthobiologics Locate Bio, an orthobiologics focused regenerative medicine company, is pleased to announce that it has raised an oversubscribed £10 million of equity investment in a funding round co-led by...
Phenotypeca is extremely pleased to announce that it has successfully raised a further £450,000 of seed investment from the UK and overseas private investors to continue the rapid growth of the business in 2021/22. This additional investment from both existing and new private investors follows...
BioCity Nottingham-based Sygnature Discovery Ltd has entered a collaboration with Epigeneron Inc., a leading Japanese bio-venture company that uses a unique cutting-edge technology to identify potential drug targets that regulate the expression of disease-related genes. The two companies have signed a multi-project collaboration agreement to develop...
IbisVision, the groundbreaking Glasgow company whose platform allows opticians to perform remote eye tests with patients in any location, has created a new role of lead developer as it builds world leading software for facial recognition. The company has hired Will Silva, a Brazilian IT...